Benzo[a]pyrene promotes proliferation of human lung cancer cells by accelerating the epidermal growth factor receptor signaling pathway.

[1]  Fabrice Cazier,et al.  Genotoxic potential of Polycyclic Aromatic Hydrocarbons-coated onto airborne Particulate Matter (PM 2.5) in human lung epithelial A549 cells. , 2008, Cancer letters.

[2]  M. Hung,et al.  Survival of cancer cells is maintained by EGFR independent of its kinase activity. , 2008, Cancer cell.

[3]  Leslie M. Tompkins,et al.  Mechanisms of cytochrome P450 induction , 2007, Journal of biochemical and molecular toxicology.

[4]  Y. Maehara,et al.  Induction of epithelial‐mesenchymal transition‐related genes by benzo[a]pyrene in lung cancer cells , 2007, Cancer.

[5]  M. Takada,et al.  The significant influence of smoking status and gender on the clinical outcome in the patients with non-small cell lung cancer: The large cohort based study , 2007 .

[6]  J Jack Lee,et al.  Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer , 2006, Cancer.

[7]  Y. Maehara,et al.  Smoking status as a prognostic factor in patients with stage I pulmonary adenocarcinoma. , 2006, The Annals of thoracic surgery.

[8]  J. Minna,et al.  Distinct Epidermal Growth Factor Receptor and KRAS Mutation Patterns in Non–Small Cell Lung Cancer Patients with Different Tobacco Exposure and Clinicopathologic Features , 2006, Clinical Cancer Research.

[9]  Robert Livingston,et al.  Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. , 2005, The New England journal of medicine.

[10]  E. Oki,et al.  Loss of heterozygosity (LOH) in non-small cell lung cancer: difference between adenocarcinoma and squamous cell carcinoma. , 2005, Respiratory medicine.

[11]  Y. Maehara,et al.  Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Min Zhang,et al.  [Expression of epidermal growth factor receptor and MUC5AC on human airway with chronic obstructive pulmonary disease]. , 2004, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.

[13]  G. Bepler,et al.  Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. , 2004, Chest.

[14]  S. Gabriel,et al.  EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.

[15]  Daniel Jones.  Anticancer drugs: To the rescue? , 2004, Nature Reviews Drug Discovery.

[16]  M. Kuwano,et al.  Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation. , 2004, Molecular cancer therapeutics.

[17]  A. Burdick,et al.  Benzo(a)pyrene quinones increase cell proliferation, generate reactive oxygen species, and transactivate the epidermal growth factor receptor in breast epithelial cells. , 2003, Cancer research.

[18]  M. Gallup,et al.  Tobacco Smoke-induced Lung Cell Proliferation Mediated by Tumor Necrosis Factor α-converting Enzyme and Amphiregulin* , 2003, Journal of Biological Chemistry.

[19]  Y. Maehara,et al.  Detection of loss of heterozygosity by high-resolution fluorescent system in non-small cell lung cancer: association of loss of heterozygosity with smoking and tumor progression. , 2003, Chest.

[20]  S. Shimba,et al.  Overexpression of the aryl hydrocarbon receptor (AhR) accelerates the cell proliferation of A549 cells. , 2002, Journal of biochemistry.

[21]  N. Tretyakova,et al.  Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers , 2002, Oncogene.

[22]  E. Tóth,et al.  Comparison of 3H-thymidine incorporation and CellTiter 96 aqueous colorimetric assays in cell proliferation of bovine mononuclear cells. , 1998, Acta veterinaria Hungarica.

[23]  Y. Nishiwaki,et al.  Role of epidermal growth factor receptor overexpression, K-ras point mutation and c-myc amplification in the carcinogenesis of non-small cell lung cancer. , 1998, Oncology reports.

[24]  M. Jaakkola,et al.  Assessment of exposure to environmental tobacco smoke. , 1997, The European respiratory journal.

[25]  K. Sugimachi,et al.  Prognostic influence of the co-expression of epidermal growth factor receptor and c-erbB-2 protein in human lung adenocarcinoma. , 1994, Surgical oncology.

[26]  W. Pryor,et al.  Oxidants in Cigarette Smoke Radicals, Hydrogen Peroxide, Peroxynitrate, and Peroxynitrite a , 1993, Annals of the New York Academy of Sciences.

[27]  R. Ueda,et al.  p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. , 1992, Cancer research.

[28]  I. Yoshino,et al.  A time trend of profile and surgical results in 1123 patients with non-small cell lung cancer. , 2002, Surgery.

[29]  K. Inoue,et al.  Polycyclic aromatic hydrocarbon carcinogens increase ubiquitination of p21 protein after the stabilization of p53 and the expression of p21. , 2000, American journal of respiratory cell and molecular biology.

[30]  P. Shields,et al.  Molecular epidemiology of lung cancer. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  K. Sugimachi,et al.  K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer. , 1997, British Journal of Cancer.

[32]  P. Wingo,et al.  Cancer statistics, 1995 , 1995, CA: a cancer journal for clinicians.

[33]  D. Jerina,et al.  Studies on the metabolism of benzo[a]pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite. , 1994, Drug metabolism reviews.

[34]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.